RecruitingNCT03887663

Chinese PD Registry

The Chinese Parkinson's Disease Registry


Sponsor

Xiangya Hospital of Central South University

Enrollment

3,000 participants

Start Date

Feb 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the Chinese Parkinson's disease Registry (CPDR) is to develop a database of patients with Parkinson's disease in China.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a patient registry in China collecting detailed clinical data on people living with Parkinson's disease (PD). The goal is to build a large, high-quality database that helps researchers better understand how Parkinson's disease develops, progresses over time, and varies across the Chinese population. Information collected will support improved treatment approaches, earlier and more accurate diagnosis, and better understanding of disease subtypes in people with PD across China and internationally. **You may be eligible if...** - You have been diagnosed with Parkinson's disease based on established UK Brain Bank criteria or other standard diagnostic criteria used in clinical practice - You are willing and able to provide consent to have your clinical data included in the registry **You may NOT be eligible if...** - You do not have the mental capacity to consent to participating in the registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Xiangya Hospital of Central South University

Changzhi, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03887663


Related Trials